Your browser doesn't support javascript.
loading
A Prospective Multicenter Evaluation of Initial Treatment Choice in Metastatic Renal Cell Carcinoma Prior to the Immunotherapy Era: The MaRCC Registry Experience.
Costello, Brian A; Bhavsar, Nrupen A; Zakharia, Yousef; Pal, Sumanta K; Vaishampayan, Ulka; Jim, Heather; Fishman, Mayer N; Molina, Ana M; Kyriakopoulos, Christos E; Tsao, Che-Kai; Appleman, Leonard J; Gartrell, Benjamin A; Hussain, Arif; Stadler, Walter M; Agarwal, Neeraj; Pachynski, Russell K; Hutson, Thomas E; Hammers, Hans J; Ryan, Christopher W; Mardekian, Jack; Borham, Azah; George, Daniel J; Harrison, Michael R.
Afiliação
  • Costello BA; Mayo Clinic, Division of Medical Oncology, Rochester, MN. Electronic address: costello.brian@mayo.edu.
  • Bhavsar NA; Duke University Medical Center, Durham, NC.
  • Zakharia Y; University of Iowa Hospitals and Clinics, Iowa City, IA.
  • Pal SK; City of Hope, Duarte, CA.
  • Vaishampayan U; University of Michigan, Ann Arbor, MI.
  • Jim H; Moffitt Cancer Center, Tampa, FL.
  • Fishman MN; Moffitt Cancer Center, Tampa, FL.
  • Molina AM; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY.
  • Kyriakopoulos CE; University of Wisconsin Carbone Cancer Center, Madison, WI.
  • Tsao CK; Tisch Cancer Institute, Mount Sinai Medical Center, New York, NY.
  • Appleman LJ; UPMC Cancer Pavilion, Pittsburgh, PA.
  • Gartrell BA; Departments of Medical Oncology and Urology, Montefiore Medical Center, Bronx, NY.
  • Hussain A; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.
  • Stadler WM; University of Chicago, Department of Medicine, Section of Hematology/Oncology, Comprehensive Cancer Center, Chicago, IL.
  • Agarwal N; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.
  • Pachynski RK; Siteman Cancer Center, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  • Hutson TE; Baylor Sammons Cancer Center-Texas Oncology, Dallas, TX.
  • Hammers HJ; University of Texas Southwestern, Dallas, TX.
  • Ryan CW; Oregon Health and Science University, Portland, OR.
  • Mardekian J; Pfizer Inc, New York, NY.
  • Borham A; Pfizer Inc, New York, NY.
  • George DJ; Duke University Medical Center, Durham, NC.
  • Harrison MR; Duke University Medical Center, Durham, NC.
Clin Genitourin Cancer ; 20(1): 1-10, 2022 02.
Article em En | MEDLINE | ID: mdl-34364796
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Observational_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Female / Humans / Male Idioma: En Revista: Clin Genitourin Cancer Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Observational_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Female / Humans / Male Idioma: En Revista: Clin Genitourin Cancer Ano de publicação: 2022 Tipo de documento: Article